- Moneycontrol /
- Market /
- Pharmaceuticals /
- QUARTERLY RESULTS
BSE Live
Apr 01, 16:00Prev. Close
136.10
Open Price
141.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 03, 15:42Prev. Close
142.00
Open Price
135.30
Bid Price (Qty.)
149.10 (1273)
Offer Price (Qty.)
0.00 (0)
| Quarterly Results of Nath Bio-Genes (in Rs. Cr.) | Dec '19 | Sep '19 | Jun '19 | Mar '19 | Dec '18 | |
| Net Sales/Income from operations | 33.06 | 21.36 | 165.32 | 52.31 | 27.88 | |
| Other Operating Income | 0.38 | 0.32 | 0.63 | 0.42 | 0.39 | |
| Total Income From Operations | 33.44 | 21.69 | 165.95 | 52.73 | 28.26 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 48.70 | 15.11 | 46.06 | 47.15 | 24.31 | |
| Purchase of Traded Goods | 2.42 | 0.25 | 1.33 | 2.83 | 0.76 | |
| Increase/Decrease in Stocks | -40.50 | -14.34 | 36.38 | -21.58 | -16.92 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 5.15 | 3.39 | 3.97 | 4.41 | 4.64 | |
| depreciat | 0.38 | 0.38 | 0.35 | 0.40 | 0.35 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | 6.05 | 6.14 | 35.85 | 7.76 | 4.49 | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 5.54 | 5.46 | 4.81 | 5.95 | 4.63 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.70 | 5.29 | 37.20 | 5.82 | 6.01 | |
| Other Income | -- | -- | -- | -- | -- | |
| P/L Before Int., Excpt. Items & Tax | 5.70 | 5.29 | 37.20 | 5.82 | 6.01 | |
| Interest | 1.63 | 1.49 | 1.73 | 1.35 | 1.74 | |
| P/L Before Exceptional Items & Tax | 4.07 | 3.81 | 35.47 | 4.48 | 4.27 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 4.07 | 3.81 | 35.47 | 4.48 | 4.27 | |
| Tax | 0.16 | 0.11 | 0.21 | -1.03 | 0.77 | |
| P/L After Tax from Ordinary Activities | 3.90 | 3.69 | 35.26 | 5.50 | 3.50 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 3.90 | 3.69 | 35.26 | 5.50 | 3.50 | |
| Equity Share Capital | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | |
| Reserves Excluding Revaluation Reserves | 531.43 | 527.53 | 523.83 | 488.58 | 483.35 | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 2.05 | 1.94 | 18.55 | 2.90 | 1.84 | |
| Diluted EPS | 2.05 | 1.94 | 18.55 | 2.90 | 1.84 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 2.05 | 1.94 | 18.55 | 2.90 | 1.84 | |
| Diluted EPS. | 2.05 | 1.94 | 18.55 | 2.90 | 1.84 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
31.01.2020
Nath Bio-Genes Standalone December 2019 Net Sales at Rs 33.44 crore, up 18.31% Y-o-Y
05.08.2019
Nath Bio-Genes Standalone June 2019 Net Sales at Rs 165.95 crore, up 30.04% Y-o-Y
30.05.2019
Nath Bio-Genes Standalone March 2019 Net Sales at Rs 52.73 crore, up 3.75% Y-o-Y
04.02.2019
Nath Bio-Genes Standalone December 2018 Net Sales at Rs 28.26 crore, up 9.63% Y-o-Y
31.01.2020
Nath Bio-Genes Standalone December 2019 Net Sales at Rs 33.44 crore, up 18.31% Y-o-Y
05.08.2019
Nath Bio-Genes Standalone June 2019 Net Sales at Rs 165.95 crore, up 30.04% Y-o-Y
30.05.2019
Nath Bio-Genes Standalone March 2019 Net Sales at Rs 52.73 crore, up 3.75% Y-o-Y
04.02.2019
Nath Bio-Genes Standalone December 2018 Net Sales at Rs 28.26 crore, up 9.63% Y-o-Y
